查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1621926

脱髮市场机会、成长动力、行业趋势分析和预测 2024 - 2032

Alopecia Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年，全球脱髮市场估值为87 亿美元，预计2024 年至2032 年间将以8.1% 的复合年增长率增长。的。遗传倾向、荷尔蒙变化、自体免疫疾病和环境压力等多种因素导致脱髮病例数量不断增加。此外，不良饮食和压力等生活方式因素会进一步加剧掉髮，促使更多人寻求有效的治疗方法。全球有数百万人受到脱髮的影响，对药物治疗和先进头髮修復技术的需求正在增加。

随着越来越多的人探索治疗脱髮的治疗方案，不断增长的患者群体推动了市场的成长。就疾病类型而言，市场分为雄性秃、斑秃和其他形式的脱髮。雄性秃（俗称斑秃）在 2023 年所占份额最大，产生约 48 亿美元的收入。雄性秃影响很大比例的男性，尤其是随着年龄的增长，它仍然是市场治疗需求的主要驱动力。

按治疗类型分类，药品在 2023 年占据领先地位，占总市场份额的 48.8%。药物治疗（无论是局部治疗还是口服治疗）的有效性得到了广泛认可，由于其非侵入性且经证实能够刺激头髮再生，因此通常是治疗脱髮的首选。它们的可及性和易用性使其成为患者的首选。北美脱髮市场在2023 年创造了32 亿美元的收入，预计到2032 年将以7.7% 的复合年增长率增长。治疗的需求。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 87 亿美元
预测值 173 亿美元
复合年增长率 8.1%

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 脱髮症盛行率增加
      • 治疗方案的技术进步
      • 人们对脱髮治疗方案的认识不断提高
      • 对药物和治疗的需求不断增长
    • 产业陷阱与挑战
      • 治疗取得方面的监管障碍
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 消费者偏好
  • 波特的分析
  • PESTEL分析
  • 未来市场趋势
  • 差距分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按疾病类型，2021 - 2032

  • 主要趋势
  • 雄性秃
  • 斑秃
  • 其他疾病类型

第 6 章：市场估计与预测：按治疗类型，2021 - 2032 年

  • 主要趋势
  • 製药
    • 专题
    • 口服
  • 装置
    • 雷射帽
    • 雷射梳
    • 雷射头盔
  • 其他治疗

第 7 章：市场估计与预测：按性别划分，2021 - 2032 年

  • 主要趋势
  • 男性
  • 女性

第 8 章：市场估计与预测：按销售管道划分，2021 - 2032 年

  • 主要趋势
  • 处方
  • 场外交易

第 9 章：市场估计与预测：依最终用途，2021 - 2032 年

  • 主要趋势
  • 皮肤科诊所
  • 家庭护理设置
  • 其他最终用户

第 10 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 11 章：公司简介

  • Apira Science, Inc. (iGROW Laser)
  • Aurobindo Pharma
  • Bosley - Hair Restoration & Transplant
  • Cipla
  • Curallux, LLC
  • Dr. Reddy's Laboratories Ltd.
  • Freedom Laser Therapy, Inc. (iRESTORE Hair Growth System)
  • Johnson & Johnson Services, Inc.
  • Lexington International., LLC
  • Merck KGaA
  • Pfizer Inc.
  • REVIAN, Inc.
  • Smart Graft
  • Sun Pharmaceuticals Industries Ltd.
  • Theradome Inc.
简介目录
Product Code: 11643

The Global Alopecia Market was valued at USD 8.7 billion in 2023 and is anticipated to grow at a CAGR of 8.1% between 2024 and 2032. The market expansion is primarily driven by the rising prevalence of alopecia and increased awareness of available treatment options. Various factors, such as genetic predispositions, hormonal changes, autoimmune conditions, and environmental stressors, contribute to the growing number of alopecia cases. Additionally, lifestyle factors like poor diet and stress further aggravate hair loss, pushing more individuals to seek effective treatments. With millions affected by alopecia globally, the demand for both pharmaceutical treatments and advanced hair restoration technologies is on the rise.

This growing patient base propels market growth, as more people explore treatment options to combat hair loss. In terms of disease type, the market is segmented into androgenetic alopecia, alopecia areata, and other forms of hair loss. Androgenetic alopecia, commonly known as pattern baldness, accounted for the largest share in 2023, generating around USD 4.8 billion in revenue. Affecting a significant percentage of men, particularly as they age, androgenetic alopecia remains a dominant driver of market demand for treatments.

When categorized by treatment type, pharmaceuticals took the lead in 2023, claiming 48.8% of the total market share. Widely recognized for their effectiveness, pharmaceutical treatments-both topical and oral-are often the first choice for treating alopecia due to their non-invasive nature and proven ability to stimulate hair regrowth. Their accessibility and ease of use make them the most preferred option among patients. North America alopecia market, which generated USD 3.2 billion in revenue in 2023, is expected to grow at a 7.7% CAGR through 2032. The high incidence of alopecia in the region, particularly androgenetic alopecia, drives the demand for innovative and effective treatments.With a large portion of the population affected by hair loss, North America continues to be a key market contributing to overall industry growth.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$8.7 Billion
Forecast Value$17.3 Billion
CAGR8.1%

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of alopecia
      • 3.2.1.2 Technological advancements in treatment regimes
      • 3.2.1.3 Growing awareness about alopecia treatment options
      • 3.2.1.4 Rising demand for drugs and treatments
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Regulatory barriers in treatment access
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Consumer preference
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Future market trends
  • 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Disease Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Androgenetic alopecia
  • 5.3 Alopecia areata
  • 5.4 Other disease types

Chapter 6 Market Estimates and Forecast, By Treatment Type, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Pharmaceutical
    • 6.2.1 Topical
    • 6.2.2 Oral
  • 6.3 Device
    • 6.3.1 Laser cap
    • 6.3.2 Laser comb
    • 6.3.3 Laser helmet
  • 6.4 Other treatments

Chapter 7 Market Estimates and Forecast, By Gender, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Male
  • 7.3 Female

Chapter 8 Market Estimates and Forecast, By Sales Channel, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Prescription
  • 8.3 OTC

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Dermatology clinics
  • 9.3 Homecare settings
  • 9.4 Other end-users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
    • 10.3.7 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
    • 10.4.6 Rest of Asia Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
    • 10.5.4 Rest of Latin America
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE
    • 10.6.4 Rest of Middle East and Africa

Chapter 11 Company Profiles

  • 11.1 Apira Science, Inc. (iGROW Laser)
  • 11.2 Aurobindo Pharma
  • 11.3 Bosley - Hair Restoration & Transplant
  • 11.4 Cipla
  • 11.5 Curallux, LLC
  • 11.6 Dr. Reddy's Laboratories Ltd.
  • 11.7 Freedom Laser Therapy, Inc. (iRESTORE Hair Growth System)
  • 11.8 Johnson & Johnson Services, Inc.
  • 11.9 Lexington International., LLC
  • 11.10 Merck KGaA
  • 11.11 Pfizer Inc.
  • 11.12 REVIAN, Inc.
  • 11.13 Smart Graft
  • 11.14 Sun Pharmaceuticals Industries Ltd.
  • 11.15 Theradome Inc.